comparemela.com

Latest Breaking News On - Susanf smith center - Page 4 : comparemela.com

Unneeded Hospital Admissions for 2/3 Low-risk Embolism Patients

Unneeded Hospital Admissions for 2/3 Low-risk Embolism Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Laying the Foundation for an Improved HR+/ HER2- Breast Cancer Treatment Paradigm

Pay-for-performance programs may only exacerbate pre-existing disparities, analysis finds

Pay-for-performance programs may only exacerbate pre-existing disparities, analysis finds
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Capivasertib/Fulvestrant Approval Expands Options in PIK3CA/AKT1/PTEN-Altered HR+/HER2– Breast Cancer

Sara M. Tolaney, MD, MPH, discusses the significance of the FDA approval of capivasertib and fulvestrant in this patient population, highlights the efficacy and notable toxicities seen in the CAPItello-291 trial, and touches on key considerations when selecting between this and other standard regimens following CDK4/6 inhibitor progression.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.